15464GS-US-695-6509Open (affiliates only)An Operationally Seamless Phase 2/3, Randomized, Active-Controlled
Study Evaluating the Safety and Efficacy of an Oral Weekly Regimen of
GS-1720 in Combination With GS-4182 Versus Biktarvy in Virologically
Suppressed People With HIV-1NCT00000000IndustrialAdultTreatmentII/IIIOtherKumar, PrincyGeorgetown University Medical Center; Lombardi Comprehensive Cancer CenterGUMC Medicine Infectious Disease; GUMC PFS2026.1.0 Build 16 <a href="https://advarra.com" target="_blank">© 2026 Advarra, Inc.</a>